Some healthcare providers may choose to implement a stepwise dose reduction (for example, decreasing from 15 mg to 10 mg to 5 mg over several weeks) not because tapering is pharmacologically required, but to allow time for: Transitioning to alternative therapies Implementing lifestyle modifications Monitoring metabolic parameters Adjusting other medications Psychological preparation for treatment changes This approach represents clinical judgment rather than medical necessity
SURMOUNT-Programm: Tirzepatid (Mounjaro) SURMOUNT-1 (2022) Adipositas ohne Diabetes: 15 mg: -20,9% (-23,6 kg) Responder (15 mg): 91% 5%, 83% 10%, 71% 15%, 57% 20% SURMOUNT-4 (2024) Gewichtserhalt: Nach Absetzen: +14% Gewichtszunahme (Placebo) vs
These tools help doctors understand how severe the stomach paralysis is
We therefore recommend using barrier contraception prior to conception. Couldwell emphasizes that these recommendations are based on a review of the research thus far, but with so many unknowns, recommendations may change
GLP-1 agonists work primarily through gut-brain signaling and slowed gastric emptying
